Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00691665 · ClinicalTrials.gov registry record · Phase 4
Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial
A Phase 4 study of Seasonal Allergic Rhinitis, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT00691665 is a Phase 4 study of Seasonal Allergic Rhinitis that has completed, run by Alcon Research. The registered enrollment target is 130 participants, below the 660-participant average among 16 other Seasonal Allergic Rhinitis trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00691665, a Phase 4 study of Seasonal Allergic Rhinitis, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparison of two nasal sprays for the treatment of seasonal allergic rhinitis
Conditions Studied
Interventions
- DRUG Olopatadine HCL Nasal Spray, 0.6%
- DRUG Fluticasone Propionate Nasal Spray, 50 mcg
Study Locations (1)
California
- Sacramento, CA - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2008-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00691665
The ClinicalTrials.gov registry entry for NCT00691665 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 660-participant average among 16 other Seasonal Allergic Rhinitis trials with a reported enrollment target (80% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Seasonal Allergic Rhinitis appearing as the primary indexed condition, and to 2 interventions - of which Olopatadine HCL Nasal Spray, 0.6% is the first listed.
NCT00691665 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00691665 about?
NCT00691665 is a clinical study titled "Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial". Comparison of two nasal sprays for the treatment of seasonal allergic rhinitis
What is the current status of trial NCT00691665?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 130 participants. The study started on 2008-05.
What conditions does trial NCT00691665 study?
This clinical trial studies the following conditions: Seasonal Allergic Rhinitis.
What interventions are being tested in trial NCT00691665?
The interventions under investigation include: Olopatadine HCL Nasal Spray, 0.6% (DRUG), Fluticasone Propionate Nasal Spray, 50 mcg (DRUG).
Who is sponsoring clinical trial NCT00691665?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00691665 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Seasonal Allergic Rhinitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit
COMPLETED · Phase 4
-
Intranasal Steroids and the Nasal Ocular Response
COMPLETED · Phase 4
-
Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid
COMPLETED · Phase 4
-
A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis
COMPLETED · Phase 4
-
A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis
COMPLETED · Phase 4
-
Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.